KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Shares Issued: 2012-2025

Historic Shares Issued for Precigen (PGEN) over the last 4 years, with Sep 2025 value amounting to $1.4 million.

  • Precigen's Shares Issued fell 95.54% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.2 million, marking a year-over-year decrease of 69.18%. This contributed to the annual value of $31.2 million for FY2024, which is 57.10% down from last year.
  • Precigen's Shares Issued amounted to $1.4 million in Q3 2025, which was up 499.15% from -$355,000 recorded in Q1 2025.
  • Over the past 5 years, Precigen's Shares Issued peaked at $121.0 million during Q1 2021, and registered a low of -$693,000 during Q2 2023.
  • Its 3-year average for Shares Issued is $15.0 million, with a median of $52,000 in 2024.
  • Its Shares Issued has fluctuated over the past 5 years, first slumped by 100.00% in 2022, then surged by 7,350,000.00% in 2023.
  • Precigen's Shares Issued (Quarterly) stood at $121.0 million in 2021, then crashed by 100.00% to $1,000 in 2022, then soared by 7,350,000.00% to -$693,000 in 2023, then surged by 107.50% to -$596,000 in 2024, then plummeted by 95.54% to $1.4 million in 2025.
  • Its Shares Issued stands at $1.4 million for Q3 2025, versus -$355,000 for Q1 2025 and -$596,000 for Q4 2024.